Comparison of the antipyretic actions of indomethacin and L-745,337, a selective cyclooxygenase-2 inhibitor, in endotoxin-treated prepubertal pigs

General Pharmacology

Volumn 30, Issue 1, 1998, Pages 65-69

  Parrott, R F ^a   Vellucci, S V ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Cortisol; Cox 1 and 2; Endotoxin; Fever; Pigs; Prostaglandin

Indexed keywords

6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPYRETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEVER; HYDROCORTISONE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SWINE; TEMPERATURE SENSITIVITY;

EID: 0031986154     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00069-4     Document Type: Article

References (18)

1. Boyce S., Chan C.-C., Gordon R., Li C.-S., Rodger I. W., Webb J. K., Rupniak N. M. J. and Hill R. G. (1994) L-745,337: A selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacol. 33, 1609-1611.
2. Chan C.-C., Boyce S., Brideau C., Ford-Hutchinson A. W., Gordon R., Guay D., Hill R. G., Li C.-S., Mancini J., Penneton M., Prasit P., Rasori R., Riendeau D., Roy P., Tagari P., Vickers P., Wong E. and Rodger I. W. (1995) Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsterodial anti-flammatory agent with an ulcerogenic sparing effect in rat and non-human primate stomach. J. Pharmacol. Exp. Ther. 274, 1531-1537.
3. Clark W. G. and Cumby H. R. (1975) The antipyretic effect of indomethaein. J. Physiol. 248, 565-635.
4. Crofford L. J., Wilder R. L., Ristimaki A. P., Sano H., Remmers E. F., Epps H. R. and Hla T. (1994) Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues; effects of interleukin-1β, phorbol ester, and corticosteriods. J. Clin. Invest. 93, 1095-1101.
5. Dinchuk J. E., Car B. D., Focht R. J., Johnson J. J., Jafee B. D., Covington M. B., Contel N. R., Eng V. M., Collins R. J., Czerniak P. M., Garry S. A. and Trzaskos J. M. (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature (Lond.). 378, 406-409.
6. Goetzl E. J., An S. and Smith W. L. (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. Faseb J. 9, 1051-1058.
7. Insel P. A. (1996) Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In Goodman & Gilman's The Pharmacological Basis of Therapeutics (Edited by Hardman J. G. and Limbird L. E.), pp. 617-657. McGraw-Hill, New York.
8. Laneuville O., Breuer D. K., Dewitt D. L., Hla T., Funk C. D. and Smith W. L. (1994) Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 271, 927-934.
9. Masferrer J. L., Reddy S. T., Zweifel B. S., Siebert K., Needleman P., Gilbert R. S. and Herschman H. R. (1994a) In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J. Phamacol. Exp. Ther. 270, 1340-1344.
10. Masferrer J. L., Zweifel B. S., Manning P. T., Hauser S. D., Leahy K. M., Smith W. G., Isakson P. C. and Siebert K. (1994b) Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatoty and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228-3232.
11. Panara M. R., Greco A., Santini G., Sciulli M. G., Rotondo M. T., Padovano R., di Giamberardino M., Cipollone F., Cuccurulla F., Patrono C. and Patrignani P. (1995) Effects of the novel anti-inflammatory compounds N-[2-(cyclohexyloxy)-4-nitrophenyl]methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4,difluorothio-phenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prostglandin and endoperoxide synthases. Br. J. Pharmacol. 116, 2429-2434.
12. Parrott R. F. and Goode J. A. (1992) Effects of intracerebroventricular corticotropin-releasing hormone and intravenous morphine on cortisol, prolactin and growth hormone secretion in sheep. Dom. Anim. Endocrinol. 9, 141-149.
13. Parrott R. F. and Vellucci S. V. (1996) Cyclooxygenase-independent mechanisms are not involved in the antipyretic action of indomethacin in the prepubertal pig. Methods Find Clin. Exp. Pharmacol. 18, 321-326.
14. Parrott R. F., Vellucci S. V., Goode J. A., Lloyd D. M. and Forsling M. L. (1995) Cyclo-oxygenase mediation of endotoxin-induced fever, anterior and posterior pituitary hormone release, and hypothalamic c-Fos expression in the prepubertal pig. Exp. Physiol. 80, 663-674.
15. Patrignani P., Panara M. R., Greco A., Fusco O., Natoli C., Iacobelli S., Cipollone F., Ganci A., Créminon C., Maclouf J. and Patrono C. (1994) Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J. Pharmacol. Exp. Ther. 27, 1705-1712.
16. Robertson R. P. (1995) Molecular regulation of prostaglandin synthesis. Trends Endocrinol. Metab. 6, 293-297.
17. Schreiber W., Kreig J.-C., Bossert S., Junker M., Rauschuber R., Stalla G. K., Muller O. A. and Berger M. (1988) Methodological aspects of hCRF-stimulated ACTH and cortisol secretion in healthy subjects. Psychoneuroendocrinol. 13, 487-495.
18. Siebert K., Masferrer J. L., Needleman P. and Salvemini D. (1996) Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney. Br. J. Pharmacol. 117, 1016-1020.